InvestorsHub Logo
Followers 6
Posts 173
Boards Moderated 0
Alias Born 05/02/2014

Re: None

Sunday, 03/29/2015 10:12:32 AM

Sunday, March 29, 2015 10:12:32 AM

Post# of 144812
Two additional clinical trials will be conducted in the U.S. by Translational Drug Development (TD2). These trials will determine the effectiveness of PharmaCyte Biotech's treatment in (i) reducing the severe pain that occurs in patients with advanced pancreatic cancer; and (ii) slowing the accumulation of malignant fluid (ascites) that accompanies the development of pancreatic and other solid cancerous tumors in the abdomen.

Read more: http://www.nasdaq.com/press-release/pharmacyte-biotech-on-track-to-commence-clinical-trials-20150327-00281#ixzz3VmfIkFAW
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News